In addition to the increased proinflammatory cytokine production, under hypoxic conditions, RA patient–derived B cells showed significantly higher expression of MMP-9 (P = 0.005), which is indicative of increased invasive capacity compared with HC-derived B cells (Figure 4D). This evidence concerns the gene MMP9 and rheumatoid arthritis.